Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Spanish reimbursement system

- PMLiVE

Otsuka’s Pletal has use restricted in Europe

EMA recommends drug only be used in limited group of patients with blood supply disorder

- PMLiVE

This month in 1980: 33 years since cyclosporine demonstrated its potential as an immunosuppressant

This month in 1980: How organ transplantation was transformed by cyclosporine

Vivus launches weight loss app to swell Qsymia sales

iPhone and Android Q and Me app backed up with patient support programme

Sanofi reception

Follow-up data suggests long-term benefit of Sanofi’s Lemtrada in MS

Drug has a durable effect on relapse rates and disability progression

- PMLiVE

NICE will take central role in UK’s value-based pricing system

DH confirms role of cost-effectiveness watchdog in drug reimbursement plans from 2014

- PMLiVE

Takeda suspended as vice president of Japanese industry body

Mis-labelling also prompts JPMA to takes action against CMO Nihon Pharmaceutical

Changes at several UK health bodies

Round-up of recent Department of Health appointments

- PMLiVE

Promising late-stage candidates for type 2 diabetes

Diabetes was first treated in the 1920s, but ever since then the quest has continued to identify and manufacture the ideal anti-diabetic treatment

PatientsLikeMe launches clinical trial search tool for patients

Online community wants to match patients to suitable studies

- PMLiVE

Additional 2,300 jobs to go at AstraZeneca

Soriot sets out strategy to return to growth

- PMLiVE

Amgen says viral melanoma therapy clears phase III trial

OncoVex demonstrates durable response in skin cancer patients

- PMLiVE

Dismay as NICE turns down Afinitor for breast cancer

Patient groups say draft guidance is a major blow to women in England and Wales

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links